Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis

NCT06201715 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Prurigo Nodularis
Itch

Interventions

DRUG: Tofacitinib 5 MG

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University